Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Tax Provisions: 2021-2024

Historic Tax Provisions for Immunocore Holdings (IMCR) over the last 4 years, with Dec 2024 value amounting to -$1.9 million.

  • Immunocore Holdings' Tax Provisions rose 118.92% to $500,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 117.37%. This contributed to the annual value of -$1.9 million for FY2024, which is 66.98% up from last year.
  • Per Immunocore Holdings' latest filing, its Tax Provisions stood at -$1.9 million for FY2024, which was up 66.98% from -$5.6 million recorded in FY2023.
  • Over the past 5 years, Immunocore Holdings' Tax Provisions peaked at $11.7 million during FY2022, and registered a low of -$5.6 million during FY2023.
  • In the last 3 years, Immunocore Holdings' Tax Provisions had a median value of -$1.9 million in 2024 and averaged $1.4 million.
  • As far as peak fluctuations go, Immunocore Holdings' Tax Provisions surged by 4,898.35% in 2022, and later tumbled by 148.05% in 2023.
  • Yearly analysis of 4 years shows Immunocore Holdings' Tax Provisions stood at -$243,000 in 2021, then soared by 4,898.35% to $11.7 million in 2022, then plummeted by 148.05% to -$5.6 million in 2023, then soared by 66.98% to -$1.9 million in 2024.